AVPR2 and nephrogenic diabetes insipidus: CC are currently under investigation for treatment of certain proteopathies or so called conformational disorders [3] such as nephrogenic diabetes insipidus caused by vasopressin V2 receptor mutants [4] or diabetes mellitus [5].